Domain Therapeutics Competitors and Similar CompaniesClear all
Domain Therapeutics's competitors and similar companies include HilleVax, Absci, Redesign Science and e-therapeutics.
 HilleVax HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. |  Redesign Science Redesign Science is a computational chemistry company specializing in small molecule drug discovery. | ||||
Founding Date | Founding Date 2001 | Founding Date 2020 | Founding Date 2011 | Founding Date 2017 | Founding Date 2003 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Illkirch-Graffenstaden, FR HQ Montréal, CA | Locations Boston, US HQ | Locations Vancouver, US HQ Belgrade, RS Zug, CH New York, US | Locations New York, US HQ | Locations Long Hanborough, GB HQ Newcastle Upon Tyne, GB |
Employees | Employees 811% decrease | Employees 31 | Employees 1561% increase | Employees 7 | Employees 58 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 95.1 m | Valuation ($) 487.2 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $2.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($147.3m) (FY, 2024) | Net income ($115.2m) (FY, 2025) | Net income N/A | Net income (£14.9m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 3.9m (about 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 2m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 41.5m | Total funding raised N/A | Total funding raised $ 217.5m | Total funding raised $ 2m | Total funding raised $ 66.8m |
For sources of this data, please see the company profile
View Company Profiles
HilleVax
HQ
Boston, US
Employees
31
HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines.
View company
Absci
HQ
Vancouver, US
Employees
156↑ 1% increase
AbSci is a company that provides generative AI drug-creation solutions.
View companyRedesign Science
HQ
New York, US
Employees
7
Redesign Science is a computational chemistry company specializing in small molecule drug discovery.
View company
e-therapeutics
HQ
Long Hanborough, GB
Employees
58
e-therapeutics is a computational drug discovery company.
View company